• 12/12/2016

    Universal Health Coverage Day

    What is UHC? Globally, 400 million people lack access to one or more essential health…

    Lees meer
  • 10/11/2016

    One of the best things of this year is that I was able to meet so many dedicated people

    Kristian van Kalmthout – former Young Professional at KNCV In 2011 Kristian graduated Maastricht University with a master degree in…

    Lees meer
  • 01/11/2016

    Visit Director of Communicable Diseases Indonesia

    Dr. Wiendra Waworuntu, Director of Communicable Diseases at the MOH of Indonesia is visiting with KNCV in the Hague this…

    Lees meer
  • 13/10/2016

    Growing evidence of extent and threat of global tuberculosis crisis

    The Hague, 13 October 2016 – Data released today by the World Health Organization (WHO) in its Global…

    Lees meer
  • 23/09/2016

    On childhood TB, stigma, and listening to care givers in Botswana

    In a thought-provoking editorial KNCV’s Dr. Ellen Mitchell reflects on an article by Stillson and colleagues on ‘Exploring challenges faced…

    Lees meer
  • 19/09/2016

    WHO launches Target Regimen Profiles for TB treatment

    Anti-TB drug research and development is focusing increasingly on testing TB drug regimens rather than on individual drugs. The development…

    Lees meer
  • 24/08/2016

    Jan Voskens (1952-2016)

    His compassion and genuine interest in people were characteristic of his work as a TB…

    Lees meer
  • 21/07/2016

    TB screening and diagnosis in Indonesian prisons

    A Memorandum of Understanding has been signed with the Ministry of Law and Human Rights in Indonesia for active TB…

    Lees meer
  • 30/06/2016

    The European Commission’s 3rd Health Program co-funds E-DETECT.

    KNCV is one of the partners in E-DETECT (early detection and integrated management of tuberculosis in Europe), a project that…

    Lees meer
  • 28/06/2016

    KNCV and European partners request Sanofi to take steps to register rifapentine with the EMA

    KNCV Tuberculosis Foundation and European partners request Sanofi to take steps to register rifapentine (Priftin®) with the European…

    Lees meer
  • 10/06/2016

    KNCV Annual Report 2015

    In 2015 KNCV Tuberculosis Foundation was active in more than 25 countries in Europe, Africa and Central and South East…

    Lees meer
  • 02/06/2016

    Zero Discrimination: International Meeting on How to Get to Zero TB Stigma

    Are TB stigmas susceptible to intervention? On May 19th 2016, Challenge TB, USAID and KNCV Tuberculosis Foundation hosted a meeting…

    Lees meer
  • 27/05/2016

    High-level international support for Nigeria’s ambitions in TB control

    Nigeria’s First Lady hailed as National Champion for TB Control at high-profile national TB conference in Abuja. Dr. Maarten…

    Lees meer
  • 19/05/2016

    Board of Trustees Appointments

    At KNCV Tuberculosis Foundation’s General Assembly on 18 May 2016, the Chair Dina Boonstra stepped down from the Board of…

    Lees meer
  • 17/05/2016

    Measuring TB Stigma

    Expert Consultation on measuring tuberculosis (TB) stigma. On May 17 and 18th, 2016, technical experts…

    Lees meer

KNCV has been fighting TB since its establishment in 1903. Over the past 120 years, the organization has acquired indispensable knowledge and experience in the field of effective TB prevention and care, resulting in pre-elimination in the Netherlands and significant contributions to global evidence generation, policy development and TB program implementation worldwide.

Our experts
KNCV governance framework and integrity
Our patroness
Partner with us

Sorry

De versie van de browser die je gebruikt is verouderd en wordt niet ondersteund.
Upgrade je browser om de website optimaal te gebruiken.